- Home
- / MAIA Biotechnology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
MAIA Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.7
2024-10-29
Market Capitalization
$65 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| General and administrative expense | 6.1M | 9.1M | 6.9M | 9.7M |
| Operating expense total | 15.5M | 10.7M | 26.1M | |
| EBIT | (16.2M) | (20.2M) | (17.0M) | (24.3M) |
| Interest income | 1.9K | 34.5K | 318.4K | |
| Interest expense | 6.9K | 57.0 | ||
| Pre tax profit | (15.8M) | (19.8M) | (23.3M) | (22.4M) |
| Income tax expense | 2.0K | |||
| Net Income | (15.8M) | (19.8M) | (23.3M) | (22.4M) |
| EPS | (1.7) | (1.0) | (1.0) | (0.7) |